Top

Archives of Osteoporosis

Published in:

01-12-2012 | Original Article

Risk factors for diminished bone mineral density among male hemodialysis patients—a cross-sectional study

Authors: Sasan Mirfakhraee, Khashayar Sakhaee, Joseph Zerwekh, Beverley Adams-Huet, Ugis Gruntmanis

Published in: Archives of Osteoporosis | Issue 1-2/2012

Abstract

Summary

This cross-sectional study was performed to characterize the factors affecting bone mass in male hemodialysis subjects. We found that of all the factors analyzed, the strongest correlation was with body mass index. In fact, after adjusting for body weight, the correlations with bone turnover markers and sex hormones were no longer significant.

Purpose

Abnormalities in bone and mineral metabolism are commonly seen in patients with end-stage renal disease, reducing bone quality and raising the risk of fracture. This cross-sectional study was performed to characterize risk factors affecting bone mass among male hemodialysis subjects.

Methods

For this cross-sectional study, we recruited 66 men from three local hemodialysis units. Subjects received dual emission X-ray absorptiometry assessment of three sites (lumbar spine, hip, and distal radius) and the values were correlated with the levels of sex hormones, non-renally excreted bone turnover markers, and mineral metabolism markers.

Results

Subjects were found to have bone mineral density (BMD) reduced predominantly at the distal radius, with Z score < −2 seen in 15.4 % and T score < −2.5 in 21 % of men. Independent predictors of bone density included levels of bone-specific alkaline phosphatase and tartrate-resistant acid phosphatase 5b, which were inversely correlated with the femoral neck Z score. Factors positively associated with an increased Z score included body mass index at all sites and free estradiol levels at the hip and distal radius. Markers of mineral metabolism (e.g., calcium, phosphate, and 25-hydroxyvitamin D) were not correlated with Z scores of any site or with bone turnover markers. After adjusting for body weight, the associations between BMD, sex hormones, and bone turnover markers were no longer significant.

Conclusion

We recommend that future studies seeking to assess the factors affecting bone strength among male hemodialysis subjects incorporate a weight-adjusted analysis. Additionally, dialysis-dependent men receiving dual emission X-ray absorptiometry should have the distal radius site added to the standard assessment.

U.S. Renal Data System. USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2010

Moe S, Drueke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lameire N, Eknoyan G (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 69:1945–1953PubMedCrossRef

Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, Andress DL (2007) Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 71:31–38PubMedCrossRef

Lehmann G, Ott U, Kaemmerer D, Schuetze J, Wolf G (2008) Bone histomorphometry and biochemical markers of bone turnover in patients with chronic kidney disease Stages 3–5. Clin Nephrol 70:296–305PubMed

Gruntmanis U (2007) Male osteoporosis: deadly, but ignored. Am J Med Sci 333:85–92PubMedCrossRef

Alem AM, Sherrard DJ, Gillen DL, Weiss NS, Beresford SA, Heckbert SR, Wong C, Stehman-Breen C (2000) Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int 58:396–399PubMedCrossRef

Mittalhenkle A, Gillen DL, Stehman-Breen CO (2004) Increased risk of mortality associated with hip fracture in the dialysis population. Am J Kidney Dis 44:672–679PubMed

Gabay C, Ruedin P, Slosman D, Bonjour JP, Leski M, Rizzoli R (1993) Bone mineral density in patients with end-stage renal failure. Am J Nephrol 13:115–123PubMedCrossRef

Ambrus C, Marton A, Nemeth ZK, Mucsi I (2010) Bone mineral density in patients on maintenance dialysis. Int Urol Nephrol 42:723–739PubMedCrossRef

10.

Sprague SM (2011) Is bone mineral density measurement of any value in a dialysis patient? Semin Dial 24:433–434PubMedCrossRef

11.

Lindergard B, Johnell O, Nilsson BE, Wiklund PE (1985) Studies of bone morphology, bone densitometry and laboratory data in patients on maintenance hemodialysis treatment. Nephron 39:122–129PubMedCrossRef

12.

Ott SM (2009) Review article: bone density in patients with chronic kidney disease stages 4–5. Nephrology (Carlton) 14:395–403CrossRef

13.

Dolgos S, Hartmann A, Bonsnes S, Ueland T, Isaksen GA, Godang K, Pfeffer P, Bollerslev J (2008) Determinants of bone mass in end-stage renal failure patients at the time of kidney transplantation. Clin Transplant 22:462–468PubMedCrossRef

14.

Stein MS, Packham DK, Ebeling PR, Wark JD, Becker GJ (1996) Prevalence and risk factors for osteopenia in dialysis patients. Am J Kidney Dis 28:515–522PubMedCrossRef

15.

Taal MW, Masud T, Green D, Cassidy MJ (1999) Risk factors for reduced bone density in haemodialysis patients. Nephrol Dial Transplant 14:1922–1928PubMedCrossRef

16.

Atsumi K, Kushida K, Yamazaki K, Shimizu S, Ohmura A, Inoue T (1999) Risk factors for vertebral fractures in renal osteodystrophy. Am J Kidney Dis 33:287–293PubMedCrossRef

17.

Urena P, Bernard-Poenaru O, Ostertag A, Baudoin C, Cohen-Solal M, Cantor T, de Vernejoul MC (2003) Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients. Nephrol Dial Transplant 18:2325–2331PubMedCrossRef

18.

Jamal SA, Hayden JA, Beyene J (2007) Low bone mineral density and fractures in long-term hemodialysis patients: a meta-analysis. Am J Kidney Dis 49:674–681PubMedCrossRef

19.

Jamal SA, Chase C, Goh YI, Richardson R, Hawker GA (2002) Bone density and heel ultrasound testing do not identify patients with dialysis-dependent renal failure who have had fractures. Am J Kidney Dis 39:843–849PubMedCrossRef

20.

Felson DT, Zhang Y, Hannan MT, Anderson JJ (1993) Effects of weight and body mass index on bone mineral density in men and women: the Framingham study. J Bone Miner Res 8:567–573PubMedCrossRef

21.

Castillo RF, de la Rosa RJ (2009) Relation between body mass index and bone mineral density among haemodialysis patients with chronic kidney disease. J Ren Care 35(Suppl 1):57–64PubMedCrossRef

22.

Ehrlich PJ, Lanyon LE (2002) Mechanical strain and bone cell function: a review. Osteoporos Int 13:688–700PubMedCrossRef

23.

Zhao LJ, Liu YJ, Liu PY, Hamilton J, Recker RR, Deng HW (2007) Relationship of obesity with osteoporosis. J Clin Endocrinol Metab 92:1640–1646PubMedCrossRef

24.

Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796–1808PubMed

25.

Halade GV, El Jamali A, Williams PJ, Fajardo RJ, Fernandes G (2011) Obesity-mediated inflammatory microenvironment stimulates osteoclastogenesis and bone loss in mice. Exp Gerontol 46:43–52PubMedCrossRef

26.

Avbersek-Luznik I, Balon BP, Rus I, Marc J (2005) Increased bone resorption in HD patients: is it caused by elevated RANKL synthesis? Nephrol Dial Transplant 20:566–570PubMedCrossRef

27.

Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C (2006) Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract 60:762–769PubMedCrossRef

28.

Finkelstein JS, Klibanski A, Neer RM, Greenspan SL, Rosenthal DI, Crowley WF Jr (1987) Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann Intern Med 106:354–361PubMed

29.

Albaaj F, Sivalingham M, Haynes P, McKinnon G, Foley RN, Waldek S, O’Donoghue DJ, Kalra PA (2006) Prevalence of hypogonadism in male patients with renal failure. Postgrad Med J 82:693–696PubMedCrossRef

30.

Doumouchtsis KK, Kostakis AI, Doumouchtsis SK, Grapsa EI, Passalidou IA, Tziamalis MP, Poulakou MV, Vlachos IS, Perrea DN (2008) The effect of sexual hormone abnormalities on proximal femur bone mineral density in hemodialysis patients and the possible role of RANKL. Hemodial Int 12:100–107PubMedCrossRef

31.

Szulc P, Munoz F, Claustrat B, Garnero P, Marchand F, Duboeuf F, Delmas PD (2001) Bioavailable estradiol may be an important determinant of osteoporosis in men: the MINOS study. J Clin Endocrinol Metab 86:192–199PubMedCrossRef

32.

Khosla S, Amin S, Orwoll E (2008) Osteoporosis in men. Endocr Rev 29:441–464PubMedCrossRef

33.

Kameda T, Mano H, Yuasa T et al (1997) Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts. J Exp Med 186:489–495PubMedCrossRef

34.

Bradford PG, Gerace KV, Roland RL, Chrzan BG (2010) Estrogen regulation of apoptosis in osteoblasts. Physiol Behav 99:181–185PubMedCrossRef

35.

Pacifici R (1996) Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 11:1043–1051PubMedCrossRef

36.

Kearns AE, Khosla S, Kostenuik PJ (2008) Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocr Rev 29:155–192PubMedCrossRef

37.

Vasikaran S, Eastell R, Bruyere O et al (2011) Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int 22:391–420PubMedCrossRef

38.

Yamada S, Inaba M, Kurajoh M, Shidara K, Imanishi Y, Ishimura E, Nishizawa Y (2008) Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction. Clin Endocrinol (Oxf) 69:189–196CrossRef

39.

Urena P, Hruby M, Ferreira A, Ang KS, de Vernejoul MC (1996) Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients. J Am Soc Nephrol 7:506–512PubMed

40.

Shidara K, Inaba M, Okuno S, Yamada S, Kumeda Y, Imanishi Y, Yamakawa T, Ishimura E, Nishizawa Y (2008) Serum levels of TRAP5b, a new bone resorption marker unaffected by renal dysfunction, as a useful marker of cortical bone loss in hemodialysis patients. Calcif Tissue Int 82:278–287PubMedCrossRef

41.

Ueda M, Inaba M, Okuno S, Maeno Y, Ishimura E, Yamakawa T, Nishizawa Y (2005) Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH. Life Sci 77:1130–1139PubMedCrossRef

42.

LaClair RE, Hellman RN, Karp SL, Kraus M, Ofner S, Li Q, Graves KL, Moe SM (2005) Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis 45:1026–1033PubMedCrossRef

43.

Elder GJ, Mackun K (2006) 25-Hydroxyvitamin D deficiency and diabetes predict reduced BMD in patients with chronic kidney disease. J Bone Miner Res 21:1778–1784PubMedCrossRef

44.

Mucsi I, Almasi C, Deak G, Marton A, Ambrus C, Berta K, Lakatos P, Szabo A, Horvath C (2005) Serum 25(OH)-vitamin D levels and bone metabolism in patients on maintenance hemodialysis. Clin Nephrol 64:288–294PubMed

45.

Stehman-Breen C et al (2000) Risk factors for hip fracture among patients with end-stage renal disease. Kidney Int 58(5):2200–2205PubMedCrossRef

46.

Danese MD, Kim J, Doan QV, Dylan M, Griffiths R, Chertow GM (2006) PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis. Am J Kidney Dis 47:149–156PubMedCrossRef

47.

Farhat GN, Cauley JA (2008) The link between osteoporosis and cardiovascular disease. Clin Cases Miner Bone Metab 5:19–34PubMed

48.

Ott SM (2008) Histomorphometric measurements of bone turnover, mineralization, and volume. Clin J Am Soc Nephrol 3(Suppl 3):S151–S156PubMedCrossRef

49.

Jamal SA, Gilbert J, Gordon C, Bauer DC (2006) Cortical pQCT measures are associated with fractures in dialysis patients. J Bone Miner Res 21:543–548PubMedCrossRef

50.

Cejka D, Patsch JM, Weber M, Diarra D, Riegersperger M, Kikic Z, Krestan C, Schueller-Weidekamm C, Kainberger F, Haas M (2011) Bone microarchitecture in hemodialysis patients assessed by HR-pQCT. Clin J Am Soc Nephrol 6:2264–2271PubMedCrossRef

Title: Risk factors for diminished bone mineral density among male hemodialysis patients—a cross-sectional study
Authors: Sasan Mirfakhraee
Khashayar Sakhaee
Joseph Zerwekh
Beverley Adams-Huet
Ugis Gruntmanis
Publication date: 01-12-2012
Publisher: Springer-Verlag
Published in: Archives of Osteoporosis / Issue 1-2/2012
Print ISSN: 1862-3522
Electronic ISSN: 1862-3514
DOI: https://doi.org/10.1007/s11657-012-0110-3

At a glance: The STEP trials

Springer Medicine

Risk factors for diminished bone mineral density among male hemodialysis patients—a cross-sectional study

Abstract

Summary

Purpose

Methods

Results

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Summary

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1-2/2012

Prevalence of vertebral fractures and quality of life in a sample of postmenopausal Brazilian women with osteoporosis

Phalangeal bone mineral density predicts incident fractures: a prospective cohort study on men and women—results from the Danish Health Examination Survey 2007–2008 (DANHES 2007–2008)

Functional fitness and bone mineral density in the elderly

Reasons for referral to bone densitometry in men and women aged 20–49 years: population-based data

Monitoring progress in the management of hip fractures in South Australia, Australia

Declining incidence of osteoporotic hip fracture in Australia